Rebecca D. Ganetzky, M.D. – FDA Inspection, Apr 18, 2025

Record Details

This FDA Inspection record concerns Rebecca D. Ganetzky, M.D., with an inspection on April 18, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Rebecca D. Ganetzky, M.D.
Inspection Date: April 18, 2025
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Sheri L. Stephenson (Company Rep)

View Company Profile

ID · bd6ddc1d-c4e6-48d6-8836-9f10fb55cbf0

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1269018
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rebecca D. Ganetzky, M.D.

FDA Inspection

Rebecca D. Ganetzky, M.D.April 18, 2025